Quick Answer
Solventum Corp reported Cash and Equivalents of $878.00 million for fiscal year 2025.
Solventum Corp Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $878.00M | +15.2% |
| 2024 | $762.00M | +292.8% |
| 2023 | $194.00M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.64B | +112.7% | +233.7% |
| June 30, 2025 | $492.00M | -45.2% | -7.9% |
| March 31, 2025 | $534.00M | -46.4% | -29.9% |
| December 31, 2024 | $762.00M | +292.8% | -1.3% |
| September 30, 2024 | $772.00M | — | -13.9% |
| June 30, 2024 | $897.00M | — | -9.9% |
| March 31, 2024 | $996.00M | — | +413.4% |
| December 31, 2023 | $194.00M | — | — |
- Solventum Corp showed an increase of +15.2% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2023–2025 period, Solventum Corp’s cash and equivalents has grown by 352.6% (from $194.00 million to $878.00 million).
- The most recent figure is from Solventum Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: